Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol in outpatient facial plastic surgery
ChiCTR2200061342Phase 4Not yet recruiting
- Sponsor
- Hangzhou Plastic Surgery Hospital
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of remimazolam in None (2 arms), sponsored by Hangzhou Plastic Surgery Hospital. Primary endpoint: Subject Satisfaction Score (ISAS score). Planned start Jun 2022; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2200061342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061342.